UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection

International journal of molecular sciences, 2022-01, Vol.23 (3), p.1049

2022

Volltextzugriff (PDF)

Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: A randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet

CNS drugs, 2003, Vol.17 (9), p.653-667

2003

Volltextzugriff (PDF)

Zolmitriptan 5 mg Nasal Spray: Efficacy and Onset of Action in the Acute Treatment of Migraine-Results From Phase 1 of the REALIZE Study

Headache, 2005-01, Vol.45 (1), p.7-16

2005

Volltextzugriff (PDF)

Analgesia and COVID-19

British journal of clinical pharmacology, 2022-07, Vol.88 (7), p.3543-3544

2022

Volltextzugriff (PDF)

Analgesia and COVID‐19

British journal of clinical pharmacology, 2022-07, Vol.88 (7), p.3543-3544

2022

Volltextzugriff (PDF)

Ibuprofen, other NSAIDs and COVID-19: a narrative review

Inflammopharmacology, 2023-10, Vol.31 (5), p.2147-2159

2023

Volltextzugriff (PDF)

Microbicidal actives with virucidal efficacy against SARS-CoV-2

American journal of infection control, 2020-08, Vol.48 (8), p.972-973

2020

Volltextzugriff (PDF)

A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality

Inflammopharmacology, 2020-10, Vol.28 (5), p.1141-1152

2020

Volltextzugriff (PDF)

Zolmitriptan Nasal Spray Exhibits Good Long-Term Safety and Tolerability in Migraine: Results of the INDEX Trial

Headache, 2005-01, Vol.45 (1), p.17-24

2005

Volltextzugriff (PDF)

Tolerability and consistency of effect of Zolmitriptan nasal spray in a long-term migraine treatment trial

CNS drugs, 2003-01, Vol.17 (11), p.839-851

2003

Volltextzugriff (PDF)

Treatment satisfaction with zolmitriptan nasal spray for migraine in a real life setting: results from phase two of the REALIZE study

Journal of headache and pain, 2005-10, Vol.6 (5), p.405-411

2005

Volltextzugriff (PDF)

Approval of inhaled insulin in Europe and United States

BMJ, 2006-03, Vol.332 (7543), p.730

Charlesworth, Bruce

2006

Volltextzugriff (PDF)

Dressing-related trauma: clinical sequelae and resource utilization in a UK setting

ClinicoEconomics and outcomes research, 2014-01, Vol.6 (default), p.227-239

2014

Volltextzugriff (PDF)

Re: Zakrzewska JM. Cluster headache: review of the literature. Br J Oral Maxillofac Surg 2001; 39: 103–113

British journal of oral & maxillofacial surgery, 2002-02, Vol.40 (1), p.85-86

Charlesworth, Bruce

2002

Volltextzugriff (PDF)

Review of zolmitriptan and its clinical applications in migraine

Expert opinion on pharmacotherapy, 2002-07, Vol.3 (7), p.993-1005

2002

Volltextzugriff (PDF)

Research Submission: Zolmitriptan 5 mg Nasal Spray: Efficacy and Onset of Action in the Acute Treatment of Migraine-Results From Phase 1 of the REALIZE Study

Headache, 2005-01, Vol.45 (1), p.7-16

2005

Volltextzugriff (PDF)

Acute treatment of migraine with Zolmitriptan 5mg orally disintegrating tablet

CNS drugs, 2004-01, Vol.18 (15), p.1133-1141

2004

Volltextzugriff (PDF)

Zolmitriptan Nasal Spray Demonstrates Fast, Reliable Efficacy in the Acute Treatment of Migraine

Headache care, 2004-03, Vol.1 (1), p.81-84

Charlesworth, Bruce R.

2004

Volltextzugriff (PDF)

Zolmitriptan Formulations Provide Fast Relief in the Acute Treatment of Migraine

Headache care, 2004-03, Vol.1 (1), p.72-74

2004

Volltextzugriff (PDF)

Zolmitriptan Orally Disintegrating Tablet (ODT) is a Highly Effective Migraine Therapy that Patients Prefer Over Other Commonly Used Treatments

Headache care, 2004-03, Vol.1 (1), p.78-80

2004

Volltextzugriff (PDF)

Research Submission: Zolmitriptan Nasal Spray Exhibits Good Long-Term Safety and Tolerability in Migraine: Results of the INDEX Trial

Headache, 2005-01, Vol.45 (1), p.17-24

2005

Volltextzugriff (PDF)

Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet

CNS drugs, 2004, Vol.18 (15), p.1133

2004

Volltextzugriff (PDF)

Intranasal Zolmitriptan 5 mg is Well Tolerated and Effective During Long-term Use for the Acute Treatment of Multiple Migraine Attacks

Headache care, 2004-12, Vol.1 (4), p.315-318

2004

Volltextzugriff (PDF)

Zolmitriptan Nasal Spray 5 mg Has a Very Fast Onset of Action and Provides Sustained Pain Relief in the Treatment of Migraine

Headache care, 2004-12, Vol.1 (4), p.261-266

2004

Volltextzugriff (PDF)

Patients Who Treat their Migraine with Zolmitriptan while the Pain is Still Mild Experience Improved Efficacy

Headache care, 2004-03, Vol.1 (1), p.75-77

2004

Volltextzugriff (PDF)

1 – 25 von 134

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(122)
Mit Volltextzugriff
(113)

Publikationsform

Sprache

Englisch
(134)

Erscheinungsjahr

n.n

Thema

Science & Technology
(89)
Life Sciences & Biomedicine
(83)
Humans
(68)
Biological And Medical Sciences
(44)
Medical Sciences
(42)
Female
(41)
Male
(41)
Surgery
(31)
Middle Aged
(30)
Adult
(28)
Multiple Sclerosis
(25)
Aged
(24)
Cardiovascular System & Cardiology
(21)
Cardiac & Cardiovascular Systems
(20)
Neurosciences & Neurology
(20)
Clinical Neurology
(19)
Surgery . Transplantations, Organ And Tissue Grafts. Graft Diseases
(18)
Prospective Studies
(17)
Risk Factors
(17)
Surgery Of The Heart
(17)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ibuprofen, Flurbiprofen, Etoricoxib or Paracetamol Do Not Influence ACE2 Expression and Activity In Vitro or in Mice and Do Not Exacerbate In-Vitro SARS-CoV-2 Infection

Speed of onset and efficacy of zolmitriptan nasal spray in the acute treatment of migraine: A randomised, double-blind, placebo-controlled, dose-ranging study versus zolmitriptan tablet

Zolmitriptan 5 mg Nasal Spray: Efficacy and Onset of Action in the Acute Treatment of Migraine-Results From Phase 1 of the REALIZE Study

Analgesia and COVID-19

Analgesia and COVID‐19

Ibuprofen, other NSAIDs and COVID-19: a narrative review

Microbicidal actives with virucidal efficacy against SARS-CoV-2

A narrative review of the potential pharmacological influence and safety of ibuprofen on coronavirus disease 19 (COVID-19), ACE2, and the immune system: a dichotomy of expectation and reality

Zolmitriptan Nasal Spray Exhibits Good Long-Term Safety and Tolerability in Migraine: Results of the INDEX Trial

Tolerability and consistency of effect of Zolmitriptan nasal spray in a long-term migraine treatment trial

Treatment satisfaction with zolmitriptan nasal spray for migraine in a real life setting: results from phase two of the REALIZE study

Approval of inhaled insulin in Europe and United States

Dressing-related trauma: clinical sequelae and resource utilization in a UK setting

Re: Zakrzewska JM. Cluster headache: review of the literature. Br J Oral Maxillofac Surg 2001; 39: 103–113

Review of zolmitriptan and its clinical applications in migraine

Research Submission: Zolmitriptan 5 mg Nasal Spray: Efficacy and Onset of Action in the Acute Treatment of Migraine-Results From Phase 1 of the REALIZE Study

Acute treatment of migraine with Zolmitriptan 5mg orally disintegrating tablet

Zolmitriptan Nasal Spray Demonstrates Fast, Reliable Efficacy in the Acute Treatment of Migraine

Zolmitriptan Formulations Provide Fast Relief in the Acute Treatment of Migraine

Zolmitriptan Orally Disintegrating Tablet (ODT) is a Highly Effective Migraine Therapy that Patients Prefer Over Other Commonly Used Treatments

Research Submission: Zolmitriptan Nasal Spray Exhibits Good Long-Term Safety and Tolerability in Migraine: Results of the INDEX Trial

Acute treatment of migraine with zolmitriptan 5 mg orally disintegrating tablet

Intranasal Zolmitriptan 5 mg is Well Tolerated and Effective During Long-term Use for the Acute Treatment of Multiple Migraine Attacks

Zolmitriptan Nasal Spray 5 mg Has a Very Fast Onset of Action and Provides Sustained Pain Relief in the Treatment of Migraine

Patients Who Treat their Migraine with Zolmitriptan while the Pain is Still Mild Experience Improved Efficacy

Suchergebnisse filtern